201
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Is Neutrophil Lymphocyte Ratio, Platelet Lymphocyte Ratio or Red Blood Cell Distribution Width Associated with Risk of Mortality in Patients with Necrotizing Fasciitis

, , , , , & show all
Pages 3861-3870 | Received 18 Mar 2023, Accepted 07 Jun 2023, Published online: 16 Jun 2023

References

  • Mulla ZD, Gibbs SG, Aronoff DM. Correlates of length of stay, cost of care, and mortality among patients hospitalized for necrotizing fasciitis. Epidemiol Infect. 2007;135(5):868–876. doi:10.1017/S0950268806007448
  • Das DK, Baker MG, Venugopal K. Increasing incidence of necrotizing fasciitis in New Zealand: a nationwide study over the period 1990 to 2006. J Infect. 2011;63(6):429–433. doi:10.1016/j.jinf.2011.07.019
  • Das DK, Baker MG, Venugopal K. Risk factors, microbiological findings and outcomes of necrotizing fasciitis in New Zealand: a retrospective chart review. BMC Infect Dis. 2012;12:348. doi:10.1186/1471-2334-12-348
  • Liu TJ, Tai H-C, Chien K-L, et al. Predisposing factors of necrotizing fasciitis with comparison to cellulitis in Taiwan: a nationwide population-based case-control study. J Formos Med Assoc. 2020;119(1 Pt 1):18–25. doi:10.1016/j.jfma.2019.01.014
  • Fontes RA, Ogilvie CM, Miclau T. Necrotizing soft-tissue infections. J Am Acad Orthop Surg. 2000;8(3):151–158. doi:10.5435/00124635-200005000-00002
  • Zahorec R. Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102(1):5–14.
  • Cheng H, Bhushan S, Li N, et al. Preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are correlated with tumor-node-metastasis stages in patients with non-small cell lung cancer. J Cancer Res Ther. 2022;18(6):1666–1673. doi:10.4103/jcrt.jcrt_473_21
  • Gawiński C, Michalski W, Mróz A, et al. Correlation between Lymphocyte-to-Monocyte Ratio (LMR), Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Tumor-Infiltrating Lymphocytes (TILs) in left-sided colorectal cancer patients. Biology. 2022;11(3). doi:10.3390/biology11030385
  • Schobert IT, Savic LJ, Chapiro J, et al. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE. Eur Radiol. 2020;30(10):5663–5673. doi:10.1007/s00330-020-06931-5
  • Noor A, Akhtar F, Tashfeen S, et al. Neutrophil-to-lymphocyte ratio, derived neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and lymphocyte-to-monocyte ratio as risk factors in critically ill COVID-19 patients, a single centered study. J Ayub Med Coll Abbottabad. 2020;32(4):S595–s601.
  • Qin B, Ma N, Tang Q, et al. Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients. Mod Rheumatol. 2016;26(3):372–376. doi:10.3109/14397595.2015.1091136
  • Karataş M, Gündüzöz M, Öziş TN, et al. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio as haematological indices of inflammatory response in ceramic workers’ silicosis. Clin Respir J. 2019;13(3):159–165. doi:10.1111/crj.12997
  • Gasparyan AY, Ayvazyan L, Mukanova U, et al. The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases. Ann Lab Med. 2019;39(4):345–357. doi:10.3343/alm.2019.39.4.345
  • Kurtipek E, Büyükterzi Z, Büyükterzi M, et al. Endothelial dysfunction in patients with pulmonary thromboembolism: neutrophil to lymphocyte ratio and platelet to lymphocyte ratio. Clin Respir J. 2017;11(1):78–82. doi:10.1111/crj.12308
  • Karahan SZ, Gazioglu S, Dilaver I, et al. The role of thrombo-inflammatory biomarkers in the prognosis of cerebral venous sinus thrombosis. Curr Neurovasc Res. 2021;18(2):237–243. doi:10.2174/1567202618666210607151518
  • Niu S, Pei Y, Hu X, et al. Relationship between the neutrophil-to-lymphocyte ratio or platelet-to-lymphocyte ratio and deep venous thrombosis (DVT) following femoral neck fractures in the elderly. Front Surg. 2022;9:1001432. doi:10.3389/fsurg.2022.1001432
  • Alexandru L, Haragus H, Deleanu B, et al. Haematology panel biomarkers for humeral, femoral, and tibial diaphyseal fractures. Int Orthop. 2019;43(7):1567–1572. doi:10.1007/s00264-019-04305-1
  • Ravindhran B, Rajan S, Kerketta D, et al. Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) versus laboratory risk indicator for necrotizing fasciitis (LRINEC) as predictors of outcome in Necrotising fasciitis. Indian J Surg. 2020;82:325–330. doi:10.1007/s12262-019-01929-w
  • Felker GM, Allen LA, Pocock SJ, et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol. 2007;50(1):40–47. doi:10.1016/j.jacc.2007.02.067
  • Allen LA, Felker GM, Mehra MR, et al. Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Card Fail. 2010;16(3):230–238. doi:10.1016/j.cardfail.2009.11.003
  • Ku NS, Kim H-W, Oh HJ, et al. Red blood cell distribution width is an independent predictor of mortality in patients with gram-negative bacteremia. Shock. 2012;38(2):123–127. doi:10.1097/SHK.0b013e31825e2a85
  • Weng CL, Wang C-H, Chen I-C, et al. Red cell distribution width is an independent predictor of mortality in necrotizing fasciitis. Am J Emerg Med. 2014;32(10):1259–1262. doi:10.1016/j.ajem.2014.08.001
  • Shih HM. Is red blood cell distribution width enough to predict prognosis of necrotizing fasciitis: author’s reply. Am J Emerg Med. 2015;33(3):468. doi:10.1016/j.ajem.2014.12.004
  • Shih HM. Can red cell distribution width predict mortality rate in patients with necrotizing fasciitis? The author’s reply. Am J Emerg Med. 2014;32(12):1538. doi:10.1016/j.ajem.2014.10.001
  • Bashaireh K, Aljararhih O, Alawneh K. Impact of body mass index on hemoglobin level and blood transfusion in total knee arthroplasty: a retrospective case control study. Ann Med Surg. 2020;55:180–184. doi:10.1016/j.amsu.2020.05.028
  • Johnson SR, Benvenuti T, Nian H, et al. Measures of admission immunocoagulopathy as an indicator for in-hospital mortality in patients with necrotizing fasciitis: a retrospective study. JB JS Open Access. 2023;8(1):154.
  • Tamhane UU, Aneja S, Montgomery D, et al. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol. 2008;102(6):653–657. doi:10.1016/j.amjcard.2008.05.006
  • Sertoglu E, Uyanik M, Kayadibi H. Is red blood cell distribution width enough to predict prognosis of necrotizing fasciitis? Am J Emerg Med. 2015;33(2):301–302. doi:10.1016/j.ajem.2014.11.021
  • Wong CH, Khin L-W, Heng K-S, et al. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004;32(7):1535–1541. doi:10.1097/01.CCM.0000129486.35458.7D
  • Crowe CS, Yu JL, Yesantharao P, et al. Predictors of mortality and amputation in patients with necrotizing soft tissue infections of the upper extremity. J Hand Surg Am. 2022;47(7):629–638. doi:10.1016/j.jhsa.2022.02.017
  • Collins CM, McCarty A, Jalilvand A, et al. Outcomes of patients with necrotizing soft tissue infections: a propensity-matched analysis using the national inpatient sample. Surg Infect (Larchmt). 2022;23(3):304–312. doi:10.1089/sur.2021.317
  • Horn DL, Shen J, Roberts E, et al. Predictors of mortality, limb loss, and discharge disposition at admission among patients with necrotizing skin and soft tissue infections. J Trauma Acute Care Surg. 2020;89(1):186–191. doi:10.1097/TA.0000000000002636
  • Huang KF, Hung M-H, Lin Y-S, et al. Independent predictors of mortality for necrotizing fasciitis: a retrospective analysis in a single institution. J Trauma. 2011;71(2):467–73; discussion 473. doi:10.1097/TA.0b013e318220d7fa
  • Holena DN, Mills AM, Carr BG, et al. Transfer status: a risk factor for mortality in patients with necrotizing fasciitis. Surgery. 2011;150(3):363–370. doi:10.1016/j.surg.2011.06.005
  • Wong CH, Chang H-C, Pasupathy S, et al. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am. 2003;85(8):1454–1460. doi:10.2106/00004623-200308000-00005
  • Hadeed GJ, Smith J, O’Keeffe T, et al. Early surgical intervention and its impact on patients presenting with necrotizing soft tissue infections: a single academic center experience. J Emerg Trauma Shock. 2016;9(1):22–27. doi:10.4103/0974-2700.173868
  • Keung EZ, Liu X, Nuzhad A, et al. Immunocompromised status in patients with necrotizing soft-tissue infection. JAMA Surg. 2013;148(5):419–426. doi:10.1001/jamasurg.2013.173
  • Anaya DA, Bulger EM, Kwon YS, et al. Predicting death in necrotizing soft tissue infections: a clinical score. Surg Infect (Larchmt). 2009;10(6):517–522. doi:10.1089/sur.2008.112
  • Cheng NC, Tai H-C, Chang S-C, et al. Necrotizing fasciitis in patients with diabetes mellitus: clinical characteristics and risk factors for mortality. BMC Infect Dis. 2015;15:417. doi:10.1186/s12879-015-1144-0